uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of...
Q2 2026
Jul 29, 2026
Q1 2026
May 5, 2026
FY 2025
Mar 2, 2026
Q4 2025
Q3 2025
Nov 10, 2025